Novogene takes in $75 mln Series B

China-based Novogene Technology Co Ltd, a provider of genomic services, has closed $75 million in Series B financing. The investors were China Merchants Bank Co. Ltd.'s CMB International, SDIC Innovation and Sigma Square Capital.

30 November 2016•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles